Tea tree oil vs azithromycin for dry eye
Part of Eyes & vision clinical trials.
This study compares two different eye drop treatments for dry eye: tea tree oil and azithromycin. It aims to see which one works better to relieve symptoms and improve tear quality.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with dry eye disease.
- Your tear film breaks up too quickly (10 seconds or less).
- You have moderate to severe dry eye symptoms (score of 20 or more on a standard test).
- You have not had any eye surgery or injury in the last 6 months.
- You are not using anti-inflammatory eye drops or pills right now.
- You are not allergic to azithromycin or tea tree oil.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two different types of eye drops for people with dry eyes that are linked to lots of screen time. It compares a new eye drop (perfluorohexyloctane) to a common one (sodium hyaluronate) to see which works better for screen-related dry eye.
This study tests an eye drop called OT202 for people with moderate to severe dry eye. It aims to see if it can help reduce dryness and improve eye comfort.
This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.
This trial tests whether a new eye drop, JN002, can help people with dry eye disease. It checks if the drops improve symptoms and eye health over time.
This trial tests a new eye drop called Ganyan-1 for people with long-term dry eye. If you have had dry eye for at least 6 months and are between 18 and 70, this study may help find a better treatment option for you.
This study tests if a new eye drop works as well as two others for people with moderate to severe evaporative dry eye, a common type caused by tear evaporation. It aims to find a better treatment option for managing symptoms.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.